1. Wei, F., Wang, H., Zhang, J. et al. Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12. J Exp Clin Cancer Res 32, 5 (2013).Ngo VL et al. Intestinal microbiota programming of alveolar macrophages influences severity of respiratory viral infection. Cell Host Microbe. 2024 Mar 13;32(3):335-348.
2. Wicks, I., Roberts, A. Targeting GM-CSF in inflammatory diseases. Nat Rev Rheumatol 12, 37–48 (2016).
3. Jiang N, Tian Z, Tang J, Ou R, Xu Y. Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells. Mediators Inflamm. 2015;2015:601604.
4. Besana, C. et al. (1994). Intensive chemotherapy with recombinant-human granulocyte-macrophage colony stimulating factor (r-hu-gm-csf) for small cell lung cancer (sclc): a pilot study. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris.
5. Mark R. Walter, William J. Cook, Steven E. Ealick, Tattanahalli L. Nagabhushan, Paul P. Trotta, Charles E. Bugg.Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor,Journal of Molecular Biology,Volume 224, Issue 4,1992